Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,338 public trials 427 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

Fesoterodine Flexible Dose Study

NCT00536484

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Chandler, Arizona, United States
  • Pfizer Investigational Site Peoria, Arizona, United States
  • Pfizer Investigational Site Tucson, Arizona, United States
View all 95 locations
View Trial Details
Completed

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

NCT00742833

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
Locations
  • Japan Hokkaido Region, Japan
  • Japan Kansai Region, Japan
  • Japan Kanto Region, Japan
  • Japan Kyushu Region, Japan
View Trial Details
Completed

Microorganism in Overactive Bladder Patients

NCT00883818

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases, +15 more
Locations
  • Inha University College of Medicine Inchon, South Korea
  • Kangnam St. Mary's Hospital, The Catholic University of Korea Seoul, South Korea
  • Asan Medical Center, Ulsan College of Medicine Seoul, South Korea
View Trial Details
Completed

TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium

NCT00077688

Conditions
Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • University of Maryland Medical Center/Greenbaum Cancer Center Baltimore, Maryland, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Completed

Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms

NCT00343486

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • GSK Investigational Site Av Córdoba 2424, Buenos Aires, Argentina
  • GSK Investigational Site Bahía Blanca, Buenos Aires, Argentina
  • GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • GSK Investigational Site Ciudad de Buenos Aires, Buenos Aires, Argentina
View all 66 locations
View Trial Details

Related conditions